Compare Cisco Systems Inc (CSCO) vs DexCom, Inc. (DXCM) Price & Performance

Cisco Systems (CSCO) trades at $117.09, down 3.48% over 24 hours, with a bullish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $1.06 exceeding the $1.03 estimate. Revenue for 2025 was $56.65 billion, with a net income margin of 19.69%. Recent news highlights Cisco's strategic AI and cybersecurity partnerships, positioning it for growth in the networking and security markets.

The outlook for CSCO is positive, supported by analyst consensus with a $130.38 price target and 52% buy ratings. Key opportunities include AI-driven security demand and solid cash flow. Risks involve competitive pressures and debt levels, with a debt-to-asset ratio of 22.97% in 2025. Investors should weigh strong fundamentals against market volatility and execution risks.

DXCM trades at $76.35, up 1.85% today, with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with 17.93% net income margin and consistent earnings beats. Recent regulatory approvals for G7 15-day CGM in Canada and pediatric clearance for Stelo OTC system highlight growth catalysts. Revenue growth accelerated to $4.66 billion in 2025, up from $4.0 billion in 2024.

DXCM presents a compelling growth story with expanding CGM market access and strong analyst support (80% buy ratings). Key risks include GLP-1 adoption impact on core market and execution of Type 2 non-insulin patient expansion. The stock trades at a premium valuation (P/E 32.76) but offers upside to consensus target of $83.78. Near-term focus on Q2 2026 earnings release July 30.